Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Hirsch

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Oncogene|August 15, 2009
The role of genetic testing in the prediction of response to EGFR inhibitors in NSCLCF R Hirsch
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 12, 2001
[Lung cancer screening--what now?]R M Bremnes, F R Hirsch
Cancer|July 1, 1980
Bone marrow involvement in small cell anaplastic carcinoma of the lung: prognostic and therapeutic aspectsF R Hirsch, H H Hansen
Acta Pathologica Japonica|July 1, 1983
Electron microscopic sub-classification of small cell carcinoma of the lungE Hage, M Hansen, F R Hirsch
Lung Cancer (Amsterdam, Netherlands)|February 25, 2000
Incidence of lung cancer in Denmark: historical and actual statusH Skuladottir, J H Olsen, F R Hirsch
Ugeskrift for Laeger|December 22, 1999
[Primary lung cancer in Denmark. Historical and current developmental tendencies]H Skuladottir, F R Hirsch, J H Olsen
Oncogene|August 15, 2009
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancerF R Hirsch, M Varella-Garcia, F Cappuzzo
Anticancer Research|January 1, 1994
Treatment of small cell lung cancer: the Copenhagen experienceF R Hirsch, P Dombernowsky, H H Hansen
Cancer|July 15, 1988
The prognostic implication of histopathologic subtyping of pulmonary adenocarcinoma according to the classification of the World Health Organization. An analysis of 259 consecutive patients with advanced diseaseJ B Sørensen, F R Hirsch, J Olsen
British Journal of Cancer|April 1, 1992
Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancerB G Skov, F R Hirsch, L Bobrow
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Oncogene|August 15, 2009
The role of genetic testing in the prediction of response to EGFR inhibitors in NSCLCF R Hirsch
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 12, 2001
[Lung cancer screening--what now?]R M Bremnes, F R Hirsch
Cancer|July 1, 1980
Bone marrow involvement in small cell anaplastic carcinoma of the lung: prognostic and therapeutic aspectsF R Hirsch, H H Hansen
Acta Pathologica Japonica|July 1, 1983
Electron microscopic sub-classification of small cell carcinoma of the lungE Hage, M Hansen, F R Hirsch
Lung Cancer (Amsterdam, Netherlands)|February 25, 2000
Incidence of lung cancer in Denmark: historical and actual statusH Skuladottir, J H Olsen, F R Hirsch
Ugeskrift for Laeger|December 22, 1999
[Primary lung cancer in Denmark. Historical and current developmental tendencies]H Skuladottir, F R Hirsch, J H Olsen
Oncogene|August 15, 2009
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancerF R Hirsch, M Varella-Garcia, F Cappuzzo
Anticancer Research|January 1, 1994
Treatment of small cell lung cancer: the Copenhagen experienceF R Hirsch, P Dombernowsky, H H Hansen
Cancer|July 15, 1988
The prognostic implication of histopathologic subtyping of pulmonary adenocarcinoma according to the classification of the World Health Organization. An analysis of 259 consecutive patients with advanced diseaseJ B Sørensen, F R Hirsch, J Olsen
British Journal of Cancer|April 1, 1992
Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancerB G Skov, F R Hirsch, L Bobrow
Pageof 8